Register for email alerts and news feeds:
This journal | BMJ Group
rss
Occupational and Environmental Medicine 2004;61:936-944; doi:10.1136/oem.2004.013128
Copyright © 2004 by the BMJ Publishing Group Ltd.
Occupational and Environmental Medicine 2004;61:936-944
© 2004 BMJ Publishing Group Ltd

ORIGINAL ARTICLE

A cross-sectional study of triallate exposure and neurological health among workers at a pesticide manufacturing and formulating facility

N Sathiakumar1, E Delzell1, P A MacLennan1, M Anne2, N L Rosenberg3, H Cheng1 and S L Myers1

1 Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Alabama, USA
2 Monsanto Company, USA
3 Deceased

Correspondence to:
Correspondence to:
Dr N Sathiakumar
Department of Epidemiology, School of Public Health, 1665 University Blvd, University of Alabama at Birmingham, Alabama, USA; nalini{at}uab.edu

Aims: To evaluate the relation between an indicator of cumulative exposure to triallate and selected measures of neurological function, including nerve conduction, the prevalence of certain neurological deficits as determined by a medical examination, and vibration perception threshold testing in workers at a pesticide manufacturing plant.

Methods: Subjects were 50 workers with high estimated triallate exposure ("high triallate" group) and 50 workers with no or low triallate exposure ("no/low triallate" group). Industrial hygienists used existing work histories and personal knowledge of plant operations to develop a triallate score. In-person interviews elicited information on past medical history and on occupational and non-occupational exposures. A neurologist carried out nerve conduction tests of the sural and the peroneal nerves, a standardised neurological examination, and vibration sensation testing.

Results: Differences between the high and the no/low triallate groups were minimal for all but one of the six nerve conduction tests, for the prevalence of neurological abnormalities, and for vibration sensation perception. The high triallate group had lower mean sural nerve peak amplitude than the no/low triallate group (11.7 v 15.2 µV, p = 0.03). This difference was reduced when adjusted for other potential risk factors (12.5 v 14.5 µV, p = 0.25) and was not associated with cumulative triallate score. We also noted several associations between factors other than triallate and nerve conduction measures.

Conclusion: The results were consistent with the absence of an association between triallate and measures of neurological function.

Keywords: triallate; pesticide; neurological function


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Work in brief
Keith Palmer
Occup. Environ. Med. 2004 61: 875a. [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Occupational, Public, Community health jobs

Occupational, Public, Community health jobs